18.01.2013 Views

EBV Conference 2008 Guangzhou - Baylor College of Medicine

EBV Conference 2008 Guangzhou - Baylor College of Medicine

EBV Conference 2008 Guangzhou - Baylor College of Medicine

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

91 (RegID: 1261)<br />

Dinesh Verma<br />

Institution: University <strong>of</strong> Florida<br />

e-mail: dinesh75@ufl.edu<br />

EPSTEIN-BARR VIRUS SM PROTEIN INHIBITS BHRF1 (VIRAL BCL-2) EXPRESSION BY<br />

DOWNREGULATING THE <strong>EBV</strong> TRANSCRIPTIONAL ACTIVATOR R PROTEIN.<br />

Dinesh Verma, Chen Ling, Nagaraja Tirumuru and Sankar Swaminathan<br />

Posterabstract:<br />

During primary infection and during reactivation from latent infection, <strong>EBV</strong> undergoes productive lytic<br />

replication. The switch from latency to lytic replication is regulated by two <strong>EBV</strong> transcriptional activators;<br />

BZLF1 (Z, Zta, EB1) and BRLF1(R, Rta). SM is an RNA-binding <strong>EBV</strong> protein expressed after Z and R<br />

during the lytic cycle and is essential for virus production. SM enhances <strong>EBV</strong> mRNA accumulation via<br />

multiple mechanisms that enhance target mRNA stability, processing and export. We have previously<br />

compared <strong>EBV</strong> gene expression in the presence and absence <strong>of</strong> SM using an epithelial cell line carrying<br />

an <strong>EBV</strong> recombinant deleted for SM. We found that most <strong>EBV</strong> genes are upregulated by SM, but one<br />

gene, BHRF1, is highly downregulated. BHRF1 is an anti-apoptotic protein that is homologous to cellular<br />

Bcl-2 and is expressed shortly after lytic <strong>EBV</strong> replication begins.<br />

To ask whether the inhibitory effect <strong>of</strong> SM on BHRF1 expression was post-transcriptional, we measured<br />

expression <strong>of</strong> BHRF1 from a heterologous promoter. SM was unable to decrease BHRF1 gene<br />

expression from a CMV promoter, suggesting that the inhibitory effect was promoter-dependent. We<br />

therefore analysed BHRF1 promoter activity with luciferase reporter assays and found that SM<br />

downregulated BHRF1 promoter activity, but only in <strong>EBV</strong>-positive cells, suggesting involvement <strong>of</strong> other<br />

<strong>EBV</strong> proteins in BHRF1 promoter inhibition by SM. We further demonstrate that SM downregulates R<br />

protein and RNA levels in <strong>EBV</strong> positive cells and that the majority <strong>of</strong> BHRF1 promoter activity in 293<br />

cells is R-dependent. Our results demonstrate that SM may inhibit BHRF1 promoter activity by<br />

downregulating R expression during the lytic phase <strong>of</strong> <strong>EBV</strong> replication and may play a role in feedback<br />

modulation <strong>of</strong> lytic cycle gene expression. Temporal modulation <strong>of</strong> BHRF1 levels during lytic replication<br />

may thus be important for maintaining cell viability for a limited period during the early stage <strong>of</strong> <strong>EBV</strong><br />

replication.<br />

<strong>EBV</strong> <strong>Conference</strong> <strong>2008</strong> <strong>Guangzhou</strong><br />

- 151 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!